The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease

Sponsor
Weibing Tang (Other)
Overall Status
Recruiting
CT.gov ID
NCT05461924
Collaborator
(none)
50
1
1.2
42.3

Study Details

Study Description

Brief Summary

Hirschsprung disease (HSCR) is characterized by the absence of ganglion cells (aganglionosis) in the distal bowel extending proximally for varying distances that results in persistent spasm in the affected bowel and functional intestinal obstruction. Patients can be classified as rectosigmoid HSCR when aganglionosis confined to the rectosigmoid and long-segment or total colonic HSCR when aganglionosis extends beyond the upper sigmoid. Aganglionosis of long-segment HSCR can extend to the descending colon, transverse colon, ascending colon, but not to the terminal ileum. To date, there is insufficient evidence to recommend a preferred or superior method for the surgical repair for long-segment HSCR. In general, a pull-through with standard of care for the intestine and mesentery, which avoids excessive resection of the colon and coloanal reconstruction, is performed for long-segment HSCR.There are reports that a significant percentage of long-segment HSCR patients continue to have difficulty with soiling and incontinence,however there were also reports long-segment HSCR patients have the same continece as rectosigmoid HSCR.The outcome of long-segment HSCR should be thoroughly evaluated. The present study was designed to evaluate the long-term outcomes of long-segment HSCR.

Condition or Disease Intervention/Treatment Phase
  • Other: questionnaire survey

Detailed Description

Hirschsprung disease (HSCR) is characterized by the absence of ganglion cells (aganglionosis) in the distal bowel extending proximally for varying distances that results in persistent spasm in the affected bowel and functional intestinal obstruction. Patients can be classified as rectosigmoid HSCR when aganglionosis confined to the rectosigmoid and long-segment or total colonic HSCR when aganglionosis extends beyond the upper sigmoid. Aganglionosis of long-segment HSCR can extend to the descending colon, transverse colon, ascending colon, but not to the terminal ileum. To date, there is insufficient evidence to recommend a preferred or superior method for the surgical repair for long-segment HSCR. In general, a pull-through with standard of care for the intestine and mesentery, which avoids excessive resection of the colon and coloanal reconstruction, is performed for long-segment HSCR.There are reports that a significant percentage of long-segment HSCR patients continue to have difficulty with soiling and incontinence,however there were also reports long-segment HSCR patients have the same continece as rectosigmoid HSCR.The outcome of long-segment HSCR should be thoroughly evaluated. The present study was designed to evaluate the long-term outcomes of long-segment HSCR.

The long-term outcome would be indicated by bowel function SCORE.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease
Actual Study Start Date :
Jul 15, 2022
Anticipated Primary Completion Date :
Aug 20, 2022
Anticipated Study Completion Date :
Aug 20, 2022

Arms and Interventions

Arm Intervention/Treatment
long-segment HSCR

Aganglionosis of non-rectosigmoid HSCR can extend to the descending colon, transverse colon, ascending colon, but not to the terminal ileum

Other: questionnaire survey
questionnaire survey the long term outcomes of long-segment HSCR and compared with rectosigmoid HSCR

rectosigmoid HSCR

Aganglionosis confined to the rectosigmoid

Other: questionnaire survey
questionnaire survey the long term outcomes of long-segment HSCR and compared with rectosigmoid HSCR

Outcome Measures

Primary Outcome Measures

  1. Bowel function score [through study completion, an average of 5 year]

    Bowel function was evaluated by the BFS (20 points), which was approved by Rintala in 1995 ; patients with a score > 18 were considered to have normal bowel habits.

Secondary Outcome Measures

  1. Hirschspurng disease associated entrocolitis(HAEC) [through study completion, an average of 5 year]

    The guidelines for the diagnosis and management of HAEC were defined by the American Pediatric Surgical Association in 2017

Eligibility Criteria

Criteria

Ages Eligible for Study:
3 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Clinical diagnosis of Hirschsprung disease Must be performed with the operation of pull-through Must be followed up more than 3 years

Exclusion Criteria:

Clinical diagnosis of Down syndrome Clinical diagnosis of tolal colonic Hirschsprung disease Clinical diagnosis of degestive malformation except Hirschsprung disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's Hospital of Nanjing Medical University Nanjing Jiangsu China 210008

Sponsors and Collaborators

  • Weibing Tang

Investigators

  • Principal Investigator: Changgui Lu, Dr, Department of pediatric surgery of Children's hospital of Nanjing medical unverisity

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Weibing Tang, Doctor, Nanjing Children's Hospital
ClinicalTrials.gov Identifier:
NCT05461924
Other Study ID Numbers:
  • NanjingCH-01
First Posted:
Jul 18, 2022
Last Update Posted:
Jul 19, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Weibing Tang, Doctor, Nanjing Children's Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2022